These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10550567)

  • 1. The pharmacokinetics of epirubicin and docetaxel in combination in rats.
    Sandström M; Simonsen LE; Freijs A; Karlsson MO
    Cancer Chemother Pharmacol; 1999; 44(6):469-74. PubMed ID: 10550567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer.
    Ichinose I; Hamada Y; Mitsuyama S; Ishikawa E; Ikeda T; Kobayashi S; Horikoshi N; Tamura K
    Chemotherapy; 2008; 54(5):379-85. PubMed ID: 18758179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.
    D'Incalci M; Schüller J; Colombo T; Zucchetti M; Riva A
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):16-20. PubMed ID: 9865687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer.
    Lunardi G; Venturini M; Vannozzi MO; Tolino G; Del ML; Bighin C; Schettini G; Esposito M
    Ann Oncol; 2002 Feb; 13(2):280-5. PubMed ID: 11886006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions.
    Ceruti M; Tagini V; Recalenda V; Arpicco S; Cattel L; Airoldi M; Bumma C
    Farmaco; 1999; 54(11-12):733-9. PubMed ID: 10668172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
    Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients.
    Sandström M; Lindman H; Nygren P; Lidbrink E; Bergh J; Karlsson MO
    J Clin Oncol; 2005 Jan; 23(3):413-21. PubMed ID: 15585753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.
    Esposito M; Venturini M; Vannozzi MO; Tolino G; Lunardi G; Garrone O; Angiolini C; Viale M; Bergaglio M; Del Mastro L; Rosso R
    J Clin Oncol; 1999 Apr; 17(4):1132. PubMed ID: 10561171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
    Danesi R; Innocenti F; Fogli S; Gennari A; Baldini E; Di Paolo A; Salvadori B; Bocci G; Conte PF; Del Tacca M
    Br J Clin Pharmacol; 2002 May; 53(5):508-18. PubMed ID: 11994057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients.
    Sandström M; Lindman H; Nygren P; Johansson M; Bergh J; Karlsson MO
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):143-56. PubMed ID: 16465545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours.
    Izquierdo MA; García M; Pontón JL; Martínez M; Valentí V; Navarro M; Gil M; Cardenal F; Mesía R; Pérez X; Salazar R; Germà-Lluch JR
    Eur J Cancer; 2006 Aug; 42(12):1789-96. PubMed ID: 16750622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.
    Cattel L; Recalenda V; Airoldi M; Tagini V; Arpicco S; Brusa P; Bumma C
    Farmaco; 2001 Oct; 56(10):779-84. PubMed ID: 11718271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel.
    van Hasselt JGC; van Calsteren K; Heyns L; Han S; Mhallem Gziri M; Schellens JHM; Beijnen JH; Huitema ADR; Amant F
    Ann Oncol; 2014 Oct; 25(10):2059-2065. PubMed ID: 24713311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
    Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients.
    Sandström M; Freijs A; Larsson R; Nygren P; Fjällskog ML; Bergh J; Karlsson MO
    J Clin Oncol; 1996 May; 14(5):1581-8. PubMed ID: 8622075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay.
    Gustafson DL; Long ME; Zirrolli JA; Duncan MW; Holden SN; Pierson AS; Eckhardt SG
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):159-66. PubMed ID: 12759775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of epirubicin hydrochloride long-circulating thermosensitive liposomes in rat plasma].
    Wu Y; Zhang FC; Wu C; Mei XG; Lü WL
    Yao Xue Xue Bao; 2010 Mar; 45(3):365-70. PubMed ID: 21351514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.